Key result
Only ~40% of hypertensive outpatients adhere to antihypertensive pharmacotherapy.
Cross-Sectional (n=156)
No
Adherence to antihypertensive pharmacotherapy is low (39.7%) among outpatients in this Colombian cohort, highlighting a significant gap in chronic disease management.
Answers are grounded in this paper and cite their sources.
Low adherence in this outpatient cohort signals need for targeted support; leaves open whether interventions improve control or outcomes in similar settings.
Introduction Hypertension is a chronic disease that impairs vital organs and alters the quality of life of patients, who must remain in drug treatment with hypotensive and vasodilator medicine to control their blood pressure. Objective To determine the degree of adherence of chronic hypertensive patients to ongoing drug therapy, as well as the relationship between their habits and attitudes with this chronic disease. Methodology Through a quantitative, descriptive and cross-sectional study based on the Morisky-Green test, a multivariate analysis of outpatients attending the hypertension control program in the Jorge Cristo Sahium Hospital, Villa del Rosario, Norte de Santander, Colombia was performed. Results The total amount of people included in the program is of 563 patients, among which a representative sample of 154 was chosen 87.34 % were women and 12.66% were men the average age was of 66.295 ± 11.393 years, and 62 (39.74%) patients completed the treatment. Conclusions The most commonly used drugs for high blood pressure were those from the antagonist pharmacological group of angiotensin II receptors (ARA II) and the angiotensin-convertingenzyme inhibitors (ACE inhibitors), together with diuretics and antiplatelet agents. Patients often discontinue their medications for certain periods of time, which causes their nonadherence to pharmacotherapy.
No takes yet. Share an insight, caveat, or question.
Carlos Julio Ramírez Pinzón (2014) conducted a cross-sectional in Hypertension (n=156). Antihypertensive pharmacotherapy was evaluated on Adherence to pharmacological treatment measured by the Morisky-Green test. Only 39.74% of hypertensive outpatients were adherent to their pharmacological treatment according to the Morisky-Green test.
Synapse has enriched 10 related papers. Consider them for comparative context: